nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
|
Markman, Maurie |
|
2012 |
124 |
1 |
p. 171- 1 p. |
artikel |
2 |
Advances in ovarian cancer disease control
|
Burger, Robert A. |
|
2012 |
124 |
1 |
p. 5-9 5 p. |
artikel |
3 |
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
|
Chi, Dennis S. |
|
2012 |
124 |
1 |
p. 10-14 5 p. |
artikel |
4 |
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
|
Elattar, Ahmed |
|
2012 |
124 |
1 |
p. 142-147 6 p. |
artikel |
5 |
A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
|
Monk, Bradley J. |
|
2012 |
124 |
1 |
p. 48-52 5 p. |
artikel |
6 |
Autoimmune mediated regulation of ovarian tumor growth
|
Altuntas, Cengiz Z. |
|
2012 |
124 |
1 |
p. 98-104 7 p. |
artikel |
7 |
Clinical outcome of patients with FIGO stage IA2 squamous cell carcinoma of the uterine cervix
|
Smrkolj, Špela |
|
2012 |
124 |
1 |
p. 68-71 4 p. |
artikel |
8 |
Correlation of TWIST2 up-regulation and epithelial–mesenchymal transition during tumorigenesis and progression of cervical carcinoma
|
Li, Yan |
|
2012 |
124 |
1 |
p. 112-118 7 p. |
artikel |
9 |
Editorial Board
|
|
|
2012 |
124 |
1 |
p. i- 1 p. |
artikel |
10 |
Exenteration in the treatment of Stage III/IV vulvar cancer
|
Forner, Dirk Michael |
|
2012 |
124 |
1 |
p. 87-91 5 p. |
artikel |
11 |
Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix
|
van Hanegem, Nehalennia |
|
2012 |
124 |
1 |
p. 72-77 6 p. |
artikel |
12 |
Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
|
Brunner, Andreas |
|
2012 |
124 |
1 |
p. 105-111 7 p. |
artikel |
13 |
“Kegel ball” induced vaginal cuff dehiscence following radical abdominal hysterectomy: Laparoscopically-assisted transvaginal retrieval
|
Bristow, Robert E. |
|
2012 |
124 |
1 |
p. 170- 1 p. |
artikel |
14 |
Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer
|
Guntupalli, Saketh R. |
|
2012 |
124 |
1 |
p. 31-35 5 p. |
artikel |
15 |
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer
|
Tanner, Edward J. |
|
2012 |
124 |
1 |
p. 59-62 4 p. |
artikel |
16 |
Pelvic exenteration with curative intent for recurrent uterine malignancies
|
Khoury-Collado, Fady |
|
2012 |
124 |
1 |
p. 42-47 6 p. |
artikel |
17 |
Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma
|
Einstein, Mark H. |
|
2012 |
124 |
1 |
p. 21-25 5 p. |
artikel |
18 |
Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma
|
Einstein, Mark H. |
|
2012 |
124 |
1 |
p. 26-30 5 p. |
artikel |
19 |
Primary radiation therapy for medically inoperable patients with clinical stage I and II endometrial carcinoma
|
Podzielinski, Iwona |
|
2012 |
124 |
1 |
p. 36-41 6 p. |
artikel |
20 |
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: What is the value of comparing apples with oranges?
|
Vergote, Ignace |
|
2012 |
124 |
1 |
p. 1-2 2 p. |
artikel |
21 |
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level
|
Lee, Yoo-Young |
|
2012 |
124 |
1 |
p. 92-97 6 p. |
artikel |
22 |
Renal ultrasound to detect hydronephrosis: A need for routine imaging after radical hysterectomy?
|
Hazewinkel, Menke H. |
|
2012 |
124 |
1 |
p. 83-86 4 p. |
artikel |
23 |
Reply to Leung et al.
|
Park, Jeong-Yeol |
|
2012 |
124 |
1 |
p. 173- 1 p. |
artikel |
24 |
Response to letter to the editor in response to “Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer”
|
O'Malley, David M. |
|
2012 |
124 |
1 |
p. 171-172 2 p. |
artikel |
25 |
Re: “The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma”
|
Leung, F. |
|
2012 |
124 |
1 |
p. 172-173 2 p. |
artikel |
26 |
Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study
|
Rossi, Emma C. |
|
2012 |
124 |
1 |
p. 78-82 5 p. |
artikel |
27 |
Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluation
|
Voss, Martin A. |
|
2012 |
124 |
1 |
p. 15-20 6 p. |
artikel |
28 |
Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: A Gynecologic Oncology Group study
|
Rungruang, Bunja |
|
2012 |
124 |
1 |
p. 53-58 6 p. |
artikel |
29 |
Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma
|
Mhawech-Fauceglia, Paulette |
|
2012 |
124 |
1 |
p. 148-152 5 p. |
artikel |
30 |
Terminology and classification system of radical hysterectomy
|
Cibula, D. |
|
2012 |
124 |
1 |
p. 174-175 2 p. |
artikel |
31 |
The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations
|
Munksgaard, Peter Svenssen |
|
2012 |
124 |
1 |
p. 164-169 6 p. |
artikel |
32 |
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
|
Chon, Hye Sook |
|
2012 |
124 |
1 |
p. 119-124 6 p. |
artikel |
33 |
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis
|
Romero, Iris L. |
|
2012 |
124 |
1 |
p. 134-141 8 p. |
artikel |
34 |
The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma
|
Park, Young-Ae |
|
2012 |
124 |
1 |
p. 125-133 9 p. |
artikel |
35 |
The more things change the more they stay the same
|
Mutch, David G. |
|
2012 |
124 |
1 |
p. 3-4 2 p. |
artikel |
36 |
There is no decision to make: Experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer
|
Meiser, B. |
|
2012 |
124 |
1 |
p. 153-157 5 p. |
artikel |
37 |
Three-dimensional classification of radical hysterectomy: New saddle for an old horse
|
Höckel, Michael |
|
2012 |
124 |
1 |
p. 173-174 2 p. |
artikel |
38 |
Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS)
|
Lifford, Kate J. |
|
2012 |
124 |
1 |
p. 158-163 6 p. |
artikel |
39 |
20year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: Impact of treatment period and concurrent chemotherapy
|
Song, Sanghyuk |
|
2012 |
124 |
1 |
p. 63-67 5 p. |
artikel |